Chemours (CC) EBT (2014 - 2026)

Chemours has reported EBT for 13 years, with the latest figure at -$22.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBT changed N/A year-over-year to -$22.0 million; the trailing twelve-month figure through Mar 2026 stood at -$299.0 million (down 886.84% YoY), and the FY2025 full-year result was $176.0 million, up 66.04% from the prior year.
• EBT for Q1 2026 stood at -$22.0 million, up from -$67.0 million in the prior quarter.
• The five-year high for EBT was $299.0 million in Q3 2022, with the low at -$433.0 million in Q2 2023.
• Average EBT over 5 years is $14.5 million, with a median of $7.0 million recorded in 2023.
• Year-over-year, EBT jumped 425.0% in 2022 and plunged 6800.0% in 2025.
• Tracing CC's EBT over 5 years: stood at -$69.0 million in 2022, then fell by 2.9% to -$71.0 million in 2023, then soared by 101.41% to $1.0 million in 2024, then sank by 6800.0% to -$67.0 million in 2025, then surged by 67.16% to -$22.0 million in 2026.
• The last three EBT figures came in at -$22.0 million (Q1 2026), -$67.0 million (Q4 2025), and $38.0 million (Q3 2025), per Business Quant data.

Peer Comparison